NO20024108D0 - Orally administered controlled delivery system for daily administration of ciprofloxacin - Google Patents

Orally administered controlled delivery system for daily administration of ciprofloxacin

Info

Publication number: NO20024108D0
Authority: NO; Norway
Prior art keywords: ciprofloxacin; delivery system; orally administered; daily administration; controlled delivery
Prior art date: 2000-03-03

Application number

NO20024108A

Other languages

Norwegian (no)

Other versions

NO20024108L (en

Inventor

Naresh Talwar

John Nicholas Staniforth

Ashok Rampal

Gour Mukherji

Badri N Vishwanathan

Brij Khera

Original Assignee

Ranbaxy Lab Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-03

Filing date

2002-08-28

Publication date

2002-08-28

2002-08-28 Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd

2002-08-28 Publication of NO20024108D0 publication Critical patent/NO20024108D0/en

2002-10-25 Publication of NO20024108L publication Critical patent/NO20024108L/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Communicable Diseases (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20024108A 2000-03-03 2002-08-28 Orally administered controlled delivery system for daily administration of ciprofloxacin NO20024108L (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US51788700A	2000-03-03	2000-03-03
PCT/IB2001/000279 WO2001064183A1 (en)	2000-03-03	2001-02-28	Orally administered controlled delivery system for once daily administration of ciprofloxacin

Publications (2)

Publication Number	Publication Date
NO20024108D0 true NO20024108D0 (en)	2002-08-28
NO20024108L NO20024108L (en)	2002-10-25

Family

ID=24061635

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20024108A NO20024108L (en)	2000-03-03	2002-08-28	Orally administered controlled delivery system for daily administration of ciprofloxacin

Country Status (31)

Country	Link
EP (1)	EP1263409A1 (en)
JP (1)	JP2003525229A (en)
KR (1)	KR20030009374A (en)
CN (1)	CN1420763A (en)
AP (2)	AP1485A (en)
AR (1)	AR032614A1 (en)
AU (1)	AU3589701A (en)
BG (1)	BG107055A (en)
BR (1)	BR0108958A (en)
CA (1)	CA2400950A1 (en)
CZ (1)	CZ20022883A3 (en)
DO (1)	DOP2001000130A (en)
EA (1)	EA200200914A1 (en)
EC (1)	ECSP013952A (en)
EE (1)	EE200200497A (en)
GT (1)	GT200100033A (en)
HN (1)	HN2001000038A (en)
HR (1)	HRP20020715A2 (en)
HU (1)	HUP0204417A3 (en)
IL (1)	IL151553A0 (en)
IS (1)	IS6532A (en)
MX (1)	MXPA02008568A (en)
NO (1)	NO20024108L (en)
NZ (1)	NZ520927A (en)
OA (1)	OA12381A (en)
PE (1)	PE20011113A1 (en)
PL (1)	PL365071A1 (en)
SK (1)	SK12542002A3 (en)
WO (1)	WO2001064183A1 (en)
YU (1)	YU66202A (en)
ZA (1)	ZA200206764B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0209265D0 (en)	2002-04-23	2002-06-05	Novartis Ag	Organic compounds
US20030229101A1 (en) *	2002-06-06	2003-12-11	Sherman Bernard Charles	Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (en)	2003-11-04	2005-06-09	Bayer Healthcare Ag	Flavor-containing drug formulations with improved pharmaceutical properties
EP1745775B1 (en)	2005-07-19	2008-05-28	Ethypharm	Gastroretentive formulations and manufacturing process thereof.
DE602006012962D1 (en) *	2006-07-19	2010-04-29	Tabuk Pharmaceutical Mfg Co	Pharmaceutical preparations of ciprofloxacin
EP3247384B1 (en)	2015-01-14	2023-10-04	The Regents of the University of Colorado, a body corporate	In vitro method of diagnosis of type 1 diabetes with insulin mimotopes
CA3015400A1 (en) *	2016-02-23	2017-08-31	Matripharm International Inc.	Dual-rate release formulation with high drug loading
CA3018727C (en)	2016-03-24	2024-03-26	The Regents Of The University Of Colorado, A Body Corporate	Methods of treating autoimmune disease
US11052060B2 (en)	2018-02-12	2021-07-06	The Regents Of The University Of Colorado, A Body Corporate	Compounds and methods for treating autoimmunity
US11013707B2 (en)	2018-03-23	2021-05-25	The Regents Of The University Of Colorado, A Body Corporate	Administration of oral methyldopa
CN109806237A (en) *	2019-03-13	2019-05-28	悦康药业集团上海制药有限公司	A kind of Ciprofloxacin Lactate effervescent tablet and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5096714A (en) *	1988-06-28	1992-03-17	Hauser-Kuhrts, Inc.	Prolonged release drug tablet formulations
JPH0624959A (en) *	1991-10-04	1994-02-01	Bayer Yakuhin Kk	Medice release solid pharmaceutical preparation of gastric suspending type sustained
DE4406424A1 (en) *	1994-02-28	1995-08-31	Bayer Ag	Expandable dosage forms
DE19839057A1 (en) *	1998-08-28	2000-03-02	Koch Berthold	Purge air controller for a drying device for compressed air
BR9913696A (en) *	1998-09-14	2001-10-09	Ranbaxy Lab Ltd	Drug delivery system, administered orally, providing temporal and spatial control

2001
- 2001-02-28 SK SK1254-2002A patent/SK12542002A3/en unknown
- 2001-02-28 CZ CZ20022883A patent/CZ20022883A3/en unknown
- 2001-02-28 CA CA002400950A patent/CA2400950A1/en not_active Abandoned
- 2001-02-28 AP APAP/P/2002/002627A patent/AP1485A/en active
- 2001-02-28 OA OA1200200267A patent/OA12381A/en unknown
- 2001-02-28 BR BR0108958-7A patent/BR0108958A/en not_active Withdrawn
- 2001-02-28 EA EA200200914A patent/EA200200914A1/en unknown
- 2001-02-28 YU YU66202A patent/YU66202A/en unknown
- 2001-02-28 AU AU35897/01A patent/AU3589701A/en not_active Abandoned
- 2001-02-28 PL PL01365071A patent/PL365071A1/en not_active Application Discontinuation
- 2001-02-28 HU HU0204417A patent/HUP0204417A3/en unknown
- 2001-02-28 EP EP01908038A patent/EP1263409A1/en not_active Withdrawn
- 2001-02-28 NZ NZ520927A patent/NZ520927A/en unknown
- 2001-02-28 WO PCT/IB2001/000279 patent/WO2001064183A1/en not_active Application Discontinuation
- 2001-02-28 KR KR1020027011441A patent/KR20030009374A/en not_active Application Discontinuation
- 2001-02-28 JP JP2001563081A patent/JP2003525229A/en not_active Withdrawn
- 2001-02-28 AR ARP010100957A patent/AR032614A1/en not_active Application Discontinuation
- 2001-02-28 IL IL15155301A patent/IL151553A0/en unknown
- 2001-02-28 EE EEP200200497A patent/EE200200497A/en unknown
- 2001-02-28 AP APAP/P/2001/002084A patent/AP2001002084A0/en unknown
- 2001-02-28 CN CN01805998A patent/CN1420763A/en active Pending
- 2001-02-28 MX MXPA02008568A patent/MXPA02008568A/en unknown
- 2001-03-01 PE PE2001000206A patent/PE20011113A1/en not_active Application Discontinuation
- 2001-03-01 EC EC2001003952A patent/ECSP013952A/en unknown
- 2001-03-01 GT GT200100033A patent/GT200100033A/en unknown
- 2001-03-02 HN HN2001000038A patent/HN2001000038A/en unknown
- 2001-03-02 DO DO2001000130A patent/DOP2001000130A/en unknown
2002
- 2002-08-23 ZA ZA200206764A patent/ZA200206764B/en unknown
- 2002-08-28 IS IS6532A patent/IS6532A/en unknown
- 2002-08-28 NO NO20024108A patent/NO20024108L/en unknown
- 2002-08-30 HR HRP20020715 patent/HRP20020715A2/en not_active Application Discontinuation
- 2002-09-02 BG BG107055A patent/BG107055A/en unknown

Also Published As

Publication number	Publication date
EA200200914A1 (en)	2003-02-27
NZ520927A (en)	2003-06-30
WO2001064183A1 (en)	2001-09-07
CZ20022883A3 (en)	2003-04-16
OA12381A (en)	2004-09-06
GT200100033A (en)	2001-10-25
HUP0204417A2 (en)	2003-05-28
ZA200206764B (en)	2003-03-04
DOP2001000130A (en)	2004-03-31
EP1263409A1 (en)	2002-12-11
IL151553A0 (en)	2003-04-10
SK12542002A3 (en)	2003-05-02
EE200200497A (en)	2004-02-16
AU3589701A (en)	2001-09-12
AP2002002627A0 (en)	2002-09-30
CN1420763A (en)	2003-05-28
ECSP013952A (en)	2002-04-23
HRP20020715A2 (en)	2004-12-31
PL365071A1 (en)	2004-12-27
AP1485A (en)	2005-10-31
PE20011113A1 (en)	2001-10-14
BR0108958A (en)	2003-09-30
KR20030009374A (en)	2003-01-29
NO20024108L (en)	2002-10-25
YU66202A (en)	2005-09-19
HUP0204417A3 (en)	2005-03-29
BG107055A (en)	2003-06-30
AP2001002084A0 (en)	2001-03-31
MXPA02008568A (en)	2003-02-24
JP2003525229A (en)	2003-08-26
CA2400950A1 (en)	2001-09-07
AR032614A1 (en)	2003-11-19
HN2001000038A (en)	2005-03-23
IS6532A (en)	2002-08-28

Similar Documents

Publication	Publication Date	Title
NO20014035D0 (en)	2001-08-20	Oral drug administration system
NO20020976L (en)	2002-03-20	Retarded, oral, pharmaceutical forms of administration
AU2002243387A1 (en)	2002-07-16	Pharmaceutical dosage form for oral administration of low molecular weight heparin
EE05123B1 (en)	2009-02-16	Means of administration of drugs having antiprogestin properties
NO20033343D0 (en)	2003-07-24	Pharmaceutical dosage forms of epothilones for oral administration
AU2002216701A1 (en)	2002-05-27	Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
HUP0302319A3 (en)	2013-04-29	Pharmaceutical composition for oral administration of active ingredient
NO20002851D0 (en)	2000-06-02	Compositions for nasal administration of drugs
NO20004823L (en)	2000-11-22	New galenic formulations of meloxicam for oral administration
CY1107465T1 (en)	2012-12-19	MELAGATRANI FOR THERAPEUTIC INFECTION
ITRM20010226A0 (en)	2001-04-24	REDUCED HEIGHT IMPLANTABLE DEVICE FOR THE ADMINISTRATION OF MEDICINAL PREPARATIONS.
NO20014738L (en)	2001-10-23	Tolperisone-containing pharmaceutical preparation for oral administration
NO20024108D0 (en)	2002-08-28	Orally administered controlled delivery system for daily administration of ciprofloxacin
EE200300371A (en)	2003-10-15	Pharmaceutical co-formulations for oral and topical administration
NO20026212D0 (en)	2002-12-23	Compound for drug delivery system and method of preparation of the compound
CA2433833A1 (en)	2002-07-25	Use of flumazenil in developing a drug for the treatment of alcohol dependence
EE200300501A (en)	2003-12-15	Formulations of imidazotriazinone for nasal administration
FI20000780L (en)	2001-10-04	Oral dosage form for controlled release of the drug
DK1225902T3 (en)	2005-05-02	Ciclesonide-containing pharmaceutical composition for administration to the mucosa
NO20031410L (en)	2003-03-27	Use of distamycin derivatives for the manufacture of drugs
NO20043007L (en)	2004-07-15	Pharmaceutical suspension for oral administration
MA27689A1 (en)	2006-01-02	ORAL GALENIC FORM FOR CONTROLLED DRUG DELIVERY
NO20032581D0 (en)	2003-06-06	Pharmaceutical formulation of gepirone for oral administration
FR2861992B1 (en)	2007-07-20	PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF A PYRAZOLE-3-CARBOXAMIDE DERIVATIVE.
ITMI992736A0 (en)	1999-12-29	PHARMACEUTICAL COMPOSITIONS FOR THE LOCALIZED ORAL ADMINISTRATION OF NON-STEREOID ANTI-INFLAMMATORY DRUGS USEFUL FOR THERAPY